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Conclusion Both nitrate and citrulline supplementation 
decreased vascular tone at rest but citrulline also altered 
sympathovagal balance to increase sympathetic tone. We 
suggest that both oral nitrate and citrulline may be suitable 
adjuvants for patients with heart failure to improve periph-
eral tissue oxygenation.
Keywords Cardiac electrical activity · Nitrate · Citrulline · 
Vascular compliance
Abbreviations
BP  Blood pressure
DP  Diastolic pressure
GTN  Glyceryl trinitrate
HF  Heart failure
HR  Heart rate
HRV  Heart rate variability
ISGE  Isometric grip exercise
LF/HF  Low frequency/high frequency ratio
MAP  Mean arterial pressure
MVC  Maximum voluntary contraction
NO  Nitric oxide
NOS  Nitric oxide synthase
PP  Pulse pressure
RPP  Rate-pressure product
SaO2  Oxygen saturation of haemoglobin (%)
SP  Systolic pressure
Δ  Change
Introduction
Heart failure (HF) is characterised by reductions in cardiac 
output and a decrease in the ability to deliver oxygen to 
peripheral tissues. This occurs as a consequence of multiple 
Abstract 
Purpose Both inorganic nitrate and citrulline are known 
to alter the arginine–nitric oxide–nitrate system to increase 
the bioavailability of nitric oxide with potential benefits in 
the treatment of heart failure. However, their effects on car-
diac electrical activity, vascular compliance and peripheral 
conductance are less well understood. This study exam-
ined the effect of nitrate and citrulline on cardiac electrical 
activity and blood flow.
Methods Young adult subjects (n = 12) were recruited to 
investigate the effects of acute oral nitrate consumption (8 mg/
kg) and chronic citrulline consumption (3 g/day) on cardiac 
electrical activity measured by ECG recording and blood pres-
sure. Blood flow and vascular compliance were measured by 
IR-plethysmography at the thumb and the hallux.
Results Nitrate (p < 0.05) and citrulline (p < 0.01) con-
sumption both decreased diastolic blood pressure but had 
no effect on either pulse pressure or rate-pressure product 
(NS for both). Citrulline also decreased systolic pressure 
(p < 0.01). Nitrate and citrulline both decreased vascular 
compliance (p < 0.05 for both) prior to isometric grip exer-
cise, but this was increased for nitrate following exercise 
(NS). Citrulline decreased R–R interval 9 % (p < 0.05) at 
rest and increased heart rate (p < 0.05) in addition to sig-
nificantly decreasing pulse transit duration (6 %; p < 0.05). 
QRS duration was also decreased by 5 % for citrulline 
(p < 0.05) with the reduction in R–R interval.
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factors, including a decrease in cardiac contractility leading to 
a decrease in cardiac output. Perhaps more insidious amongst 
the consequences of HF is the increase in sympathetic tone 
which leads to an increase in heart rate (HR) initially and 
also increased vascular tone. As a result, ventricular filling is 
decreased hence contributing to a diminished cardiac output.
Therapies that increase ventricular filling without alter-
ing heart rate, therefore, have the potential to increase 
cardiac output without increasing cardiac oxygen demand 
through tachycardia. Acute exploitation of nitrate-releasing 
agents decreases heart rate, both systolic and diastolic blood 
pressures and, as a consequence, increases the left ventricu-
lar ejection fraction (Battock et al. 1976). Disadvantages to 
such therapies include poor potential to maintain systemic 
blood pressure. Amongst the therapies exploited include 
the organic nitrates (e.g. glycerol trinitrate-GTN) releasing 
nitric oxide in the systemic circulation, reducing left ven-
tricular filling pressure and increasing cardiac index sug-
gesting improvement in cardiac performance (Franciosa 
et al. 1978) through decreasing both preload and afterload 
(Kelly et al. 1990). Indeed, arteriolar and venular compo-
nents of the cardiovascular system have differing sensitivi-
ties to GTN, with venous distension maximal at very low 
nitrate concentrations whilst arterial resistance shows lower 
sensitivities to GTN (Imhof et al. 1980). This holds the 
benefit for decreasing afterload whilst helping to preserve 
systemic arterial blood pressure. One shortcoming of such 
therapies is a gradual attenuation of the efficacy of organic 
nitrates (Leier et al. 1983).
More recently, inorganic nitrate found in certain fruit and 
vegetable juices has shown the potential to reduce blood 
pressure (Siervo et al. 2013) and for the improvement in 
cardiovascular parameters including vascular compliance 
(Lidder and Webb 2012). In addition, athletes have subse-
quently found ergogenic benefit from nitrate consumption 
with the potential to decrease systemic blood pressure and 
decrease oxygen consumption for fixed workloads (Larsen 
et al. 2010; Bailey et al. 2009; Vanhatalo et al. 2010). In 
healthy normotensive subjects, inorganic nitrate increased 
vascular compliance without altering flow-mediated dilata-
tion (Bahra et al. 2012). Recent experiments also suggest 
that inorganic nitrate may also offer the potential to ame-
liorate disease; whilst consumption of nitrate-rich beetroot 
juice did not alter the exercise capacity of patients with 
COPD, oxygen consumption during exercise was decreased 
(Curtis et al. 2015). Furthermore, dietary nitrate improved 
endothelial function and decreased vascular stiffness in 
older adults (Rammos et al. 2014). All these effects have 
potential benefits in heart failure. Indeed, for patients with 
HF and preserved ejection fraction, nitrate supplementation 
increased exercise duration, total work and increased both 
peak oxygen extraction and cardiac output (Zamani et al. 
2015).
Citrulline, the end product of arginine-mediated nitric 
oxide production, has shown the potential to increase 
plasma nitrate and NO availability (Schwedhelm et al. 
2007; Morita et al. 2014). In addition, citrulline decreased 
blood pressure and does not demonstrate the desensitisation 
noted for GTN. Citrulline does not complex with haemo-
globin and, therefore, decrease oxygen carriage, increases 
both plasma arginine and cGMP (Schwedhelm et al. 2007) 
and is free of side effects. In human subjects, citrulline 
decreased arterial stiffness in middle-aged men (Ochiai 
et al. 2012). Citrulline also attenuated the systolic pressure 
(SP) increase in response to the cold pressor test (Figueroa 
et al. 2010). More recently, citrulline has shown promise 
as an intervention for hypertension, reducing both blood 
pressure and cardiac augmentation index in obese pre- and 
hypertensive subjects (Figueroa et al. 2012). Together, 
these observations suggest that citrulline may also show 
benefit in human subjects for the improvement of oxygen 
delivery in heart failure. However, alterations to cardiac 
electrical activity and profound changes to blood pressure, 
heart rate or increases in tone of the sympathetic nervous 
system would preclude the use of citrulline.
We postulate that in healthy adults, both nitrate and 
citrulline supplementation will decrease blood pressure 
through peripheral vascular effects rather than decreasing 
heart rate. Nitrate and citrulline will also preserve cardiac 
electrical activity and will not alter sympathetic tone in 
response to acute increases in sympathetic nerve function, 
therefore, making citrulline a potential treatment for HF. 
We will examine the impact of nitrate and citrulline supple-
mentation in young adults, measuring blood pressure and 
electrocardiogram characteristics. In addition, we will esti-




Food grade salt petre (potassium nitrate) was purchased 
from Anglia Chemical Products (Ipswich, Suffolk, UK) and 
citrulline tablets were obtained from Source Naturals Inc. 
(Santa Cruz, CA, USA).
Methods
Ethical review
All experiments were approved by the Maths and Physi-
cal Sciences and Engineering joint Faculty Research Ethics 
Committee (MEEC), University of Leeds (Review Number: 
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MEEC 14-028) and all studies complied with the Declara-
tion of Helsinki. Young adults who were non-smokers were 
recruited to the experiments; criteria for exclusion included 
existing cardiac and kidney disease, diabetes, hypertension 
and Raynaud’s disease. All subjects gave their informed con-
sent to participate in the experiments. Subjects attended the 
study facility on two separate occasions, separated by at least 
1 week; all subjects were fasted overnight, well rested, had 
abstained from caffeine during the previous 12 h and had not 
undertaken vigorous exercise within the previous 24 h period.
Experimental protocol
Anthropomorphic measurements including height and body 
mass were recorded. Body composition was estimated 
using bioimpedance analysis scales (Omron Healthcare 
Inc., Bannockburn, Illinois, USA). Maximum Voluntary 
Contraction (MVC) isometric grip (ISGE) strength was 
estimated using digital hand-grip using the non-dominant 
hand. Briefly, maximum grip strength was estimated fol-
lowing three maximum grip tests, a minimum of 30 secs 
apart. 30 % MVC was calculated from the mean of 3-maxi-
mal contractions. Oxygen saturation of haemoglobin 
(SaO2) was estimated using pulse oximeter (Anapulse, 
Ana Wiz Ltd, Surbiton, Surrey, UK) and data expressed as 
%-haemoglobin saturation.
All subjects were then instrumented to record periph-
eral pulse amplitude using IR plethysmograph attached to 
thumb and hallux (MLT-1020, AD Instruments, Oxford, 
UK). Blood pressure was measured using peripheral blood 
pressure cuff. ECG was recorded using 3-lead ECG record-
ing equipment (Bio-Amp, AD Instruments, Oxford, UK) 
attached by adhesive electrodes to the inner surface of the 
dominant forearm, shoulder of the non-dominant arm and 
one ankle. All data were recorded via a datalogger (Pow-
erLab 4/35, AD Instruments, Oxford, UK) to computer for 
further analysis. Subjects were seated in a relaxed position 
and spontaneously breathing.
Blood flow and ECG were continuously recorded during 
10 min rest period. Blood pressure was measured periodi-
cally (5 min). At 10 min, following a maximal inhalation 
a 30 s breath-hold was undertaken (Fig. 1), followed by a 
return to spontaneous breathing for a further 10 min. Sub-
jects were then asked to sustain a grip test using the non-
dominant hand estimated at 30 % MVC for 3 min. Blood 
flow and ECG measurements were continued throughout 
(Fig. 1). Following a return to baseline measurements, sub-
jects were provided with sugar-free fruit cordial containing 
a nitrate supplement (8 mg/kg body mass) and remained 
within the study facility for a further 2 h prior to repeating 
the above test protocol. Following this second test, subjects 
were supplied with citrulline tablets (3 g/day) and asked to 
consume tablets for 7 days, in one single dose. At 7 days, 
subjects returned to the study facility to repeat the above 
test protocol (Fig. 1).
Data analysis
Using 30 s averages, heart rate (HR) HR maximum and 
minimum and HR range were estimated. Systolic (SP) and 
diastolic pressures (DP) were recorded, with mean arterial 
pressure (MAP) calculated (MAP = [SP − DP]/3 + DP) 
and rate-pressure product (RPP) calculated as systolic 
pressure x heart rate. Pulse pressure (PP) was calculated 
as PP = SP − DP. Heart rate variability (HRV) was esti-
mated from ECG using proprietary software (Chart 8.0, AD 
Instruments, Oxford, UK). Optimal settings for well-defined 
R waves were as follows: range 2 mV, high pass 0.3 Hz, 
























































































Fig. 1  Experimental protocol timeline for human experiments
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to calculate (beats min−1) and R–R intervals (ms), as well 
as the relative duration of the cardiac cycle components 
(sampled at 1 kHz). A minimum of 500 consecutive heart 
beats were examined. Peripheral pulse wave analysis in the 
time domain was undertaken using proprietary software 
(Chart 8.0, AD Instruments, Oxford), as previously detailed 
(Korpas et al. 2009; Allen and Murray 2002). To estimate 
the time delay between contraction of the ventricle and 
pulse delivery to the thumb or hallux pulse time was meas-
ured with regard to ECG. For 25 consecutive heart beats, 
pulse duration was measured as the duration between the 
R peak for an individual heart-beat and the pulse maximum 
for IR-plethysmograph recording for both thumb and Hal-
lux. To estimate peripheral vascular compliance, the ratio 
of pulse amplitudes measured at the maximum and at the 
dicrotic notch was estimated for 25 consecutive heart beats 
at thumb (Klemsdal et al. 1996; Gunarathne et al. 2008).
Data are presented as mean ± SEM; statistical analysis 
was carried out using students ‘t’ test to examine the effects 
of nitrate or citrulline; analysis of variance (ANOVA) was 
used to quantify the effect of treatments with Bonferroni 
post hoc test to account for multiple comparisons.
Results
Anthropometry
12 subjects (mean age 22.8 ± 2.0 years; Table 1) enrolled 
for the experiment and all subjects completed both the 
nitrate and citrulline arms of the experiments. Nitrate sup-
plementation decreased systolic pressure 3 %, but this 
was not significantly different from untreated subjects 
(NS; Table 1). By contrast, citrulline decreased SP 6 % 
(p < 0.01; Table 2). Diastolic blood pressure (DP) was 
reduced 6 % (p < 0.05; Table 2) by nitrate whereas citrul-
line decreased DP 14 % (p < 0.01; Table 2). By calcula-
tion, mean arterial pressure (MAP) was decreased 5 % by 
nitrate treatment (p < 0.05; Table 2), whereas citrulline 
reduced MAP 10 % (p < 0.01; Table 2). Rate-pressure 
product (RPP) was unaffected by either nitrate or citrul-
line treatment (NS for both; Table 2). Citrulline treatment 
decreased MVC by 7 % compared with untreated con-
trols (p < 0.05; Table 2). Haemoglobin % oxygen satura-
tion, measured by pulse oximetry, was unaffected by cit-
rulline but was decreased 2 % by nitrate supplementation 
(p < 0.001; Table 2).
Electrocardiogram
For untreated subjects, breath-hold increased HR 7 % (NS; 
Fig. 2a) whilst isometric grip exercise increased HR 11 % 
(p < 0.05; Fig. 2a). This was accompanied by correspond-
ing decreases in R–R interval following ISGE (p < 0.05; 
Fig. 2b). Nitrate supplementation led to an 11 % decrease 
in HR during breath-hold (NS; Fig. 2a) accompanied by a 
corresponding increase in R–R interval (NS; Fig. 2b). Cit-
rulline increased HR 9 % (p < 0.05; Fig. 2a) and decreased 
R–R interval significantly (p < 0.05; Fig. 2b) for subjects 
Table 1  Anthropometric characterisation of subjects
Parameter Measurement
Age (years) 22.8 ± 2.0
Subjects (M/F) 12 (M = 4/F = 8)
Body mass (kg) 73.8 ± 3.0
Height (cm) 171 ± 2
Body mass index (kg/m2) 25.2 ± 0.7
Body fat mass (%) 31.0 ± 1.9
Muscle mass (%) 31.2 ± 1.5
Visceral fat (g) 5.8 ± 0.8
Table 2  Effects of nitrate and 
citrulline on cardiovascular 
parameters in human subjects
Measurements of cardiovascular parameters for subjects at rest. Data represent mean ± SEM for n = 12 
subjects
ND not determined
Statistical significance represented as different from untreated subjects: * p < 0.05, ** p < 0.01, 
*** p < 0.001
Measurement Untreated Nitrate (8 mg/kg) Citrulline (3 g/day)
Systolic pressure (mmHg) 126.2 ± 3.3 122.1 ± 4.0 118.0 ± 3.7**
Diastolic pressure (mmHg) 78.0 ± 4.0 72.9 ± 2.7* 67.6 ± 2.8**
Mean arterial pressure (mmHg) 94.2 ± 3.3 89.3 ± 2.7* 84.4 ± 2.6**
Pulse pressure (mmHg) 48 ± 2 49 ± 4 50 ± 3
Heart rate (bpm) 76.9 ± 3.6 75.0 ± 3.0 78.0 ± 3.9
Rate-pressure product (mmHg/min) 9673 ± 473 9068 ± 249 9190 ± 467
Maximum voluntary contraction (kg) 37.5 ± 3.6 ND 35.0 ± 3.3*
Haemoglobin oxygen saturation [SaO2] (%) 98.1 ± 0.2 96.3 ± 0.4*** 97.8 ± 0.2
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at rest. However, during both breath-hold and ISGE both 
HR (NS; Fig. 2a) and R–R interval (NS; Fig. 2b) were 
unchanged by citrulline supplementation.
Estimation of the domain-averaged durations for the 
cardiac events P, P-R, Q-T, Q-Tc, T, R-T, J-T and S-T was 
unchanged by either physiological intervention—breath-
hold or ISGE—or by supplement—nitrate of citrulline 
(NS for all; data not shown). However, for subjects at rest, 
citrulline decreased QRS interval 5 % (p < 0.05; Fig. 2c), 
whilst QRS interval was unchanged following nitrate sup-
plementation (NS; Fig. 2c).
Pulse interval
Pulse interval measured at the hallux was signifi-
cantly greater than pulse interval measured at the thumb 
(p < 0.001; Fig. 3a, b). For subjects at rest, both nitrate and 
citrulline decreased pulse interval measured at the thumb 
15 %, for nitrate treatment this did not reach statistical 
significance (NS; Fig. 3a), whereas for citrulline this was 
significantly different from untreated subjects (p < 0.05; 
Fig. 3a). For the hallux mean pulse interval was decreased 
30 % by nitrate (p < 0.05; Fig. 3b) and decreased 35 % by 
Fig. 2  Cardiac electrical 
activity. Estimates of heart rate 
following nitrate and citrulline 
supplementation. Data represent 
maximum, 3rd quartile, median, 
1st quartile and minimum HR 
(a). Estimates of cardiac R–R 
interval after nitrate or citrul-
line at rest (b). Measured QRS 
complex duration in subjects 
following nitrate and citrulline 
supplementation (c). For further 
details see methods. Data 
represent mean ± SEM (n = 12 
subjects). Statistical significance 
indicated as: different from 
untreated control: *p < 0.05: 
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citrulline (p < 0.05; Fig. 3b). Following ISGE, both nitrate 
and citrulline had no effect mean pulse interval measured at 
the thumb (NS for both; Fig. 3a) compared with untreated 
controls. However, mean pulse interval at the hallux was 
further decreased 35 % by nitrate (p < 0.05; Fig. 3b) and 
55 % by citrulline (p < 0.01; Fig. 3b).
Peripheral IR plethysmography
Compliance of the peripheral vasculature, estimated from 
relative peak height of the dicrotic notch to the peak pulse 
amplitude (pulse amplitude ratio-PAR), was calculated from 
peripheral pulse signal. For untreated subjects, PAR was 
unchanged as a result of 30 % MVC-ISGE (NS; Fig. 4a). 
Following nitrate supplementation, PAR decreased 15 % 
(p < 0.05; Fig. 4a) at rest (Time t = 0 to t = 10 min). How-
ever, during ISGE this trend was lost (NS; Fig. 4a) and at 
completion of the exercise PAR showed a modest decrease 
to pre-exercise levels (NS; Fig. 4a). By contrast, citrulline 
supplementation significantly decreased PAR ~30 % during 
the rest period (p < 0.05; Fig. 4b); however, on the initiation 
of isometric grip exercise at 30 % ISGE PAR increased rela-
tive to untreated, such that it was not significantly different 
from the untreated controls (NS; Fig. 4b). During the sub-
sequent recovery period, PAR declined following citrulline 
treatment and the significant difference from untreated sub-
jects was restored (p < 0.05; Fig. 4b).
Heart rate variability
Heart rate variability (HRV) was estimated from ECG 
traces and data represented the balance of sympathetic out-
puts as the ratio between low frequency and high frequency 
outputs (Fig. 5). For subjects at rest, nitrate treatment had 
no effect on sympathovagal balance (NS; Fig. 5); however, 
citrulline treatment increased LF/HF by one-third, imply-
ing an increase in contribution from sympathetic nervous 
system (p < 0.05; Fig. 5). Irrespective of treatment, breath-
hold increased sympathetic tone, measured as LF/HF ratio 
4-fold (p < 0.001 for all; Fig. 5); however, neither nitrate 
nor citrulline had any additional effect on HRV estimates 
(NS; Fig. 5). ISGE at 30 % MVC did not increase measures 
Fig. 3  Pulse interval for periph-
eral blood flow at thumb (a) 
and Hallux (b). Pulse interval 
was calculated as duration 
between R–R interval and peak 
peripheral pulse. (d). For further 
details, see methods. Data 
represent maximum, 3rd quar-
tile, median, 1st quartile and 
minimum HR (n = 12 subjects). 
Statistical significance indicated 
as: different from untreated 
control: *p < 0.05, **p < 0.01: 
different from pulse interval at 
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of sympathovagal balance compared with the correspond-
ing controls; however, the one-third increase noted for cit-
rulline compared with untreated subjects was preserved 
(p < 0.05; Fig. 5).
HR augmentation in response to exercise
ISGE increased heart rate 6.6 ± 1.7 bpm for untreated 
subjects (Fig. 6). For nitrate-supplemented subjects, this 
increase was preserved, nitrate having no effect on HR 
augmentation during exercise. By contrast, the increase 
in HR during exercise was 2.7 ± 1.7 bpm for citrulline-
treated subjects and hence the augmentation in response to 
exercise was approximately halved by citrulline (p < 0.05; 
Fig. 6).
Discussion
Manipulation of the arginine–nitric oxide pathway has 
demonstrated the potential to improve cardiovascular func-
tion (Wu and Meininger 2000) and we confirm that either 
acute nitrate supplementation or chronic citrulline supple-
mentation decreased mean arterial pressure and diastolic 
pressure, implying a decrease in total peripheral resistance 
(Cowley et al. 1973). Despite the apparent hypotension, 
cardiac rate-pressure product (RPP) was unchanged sug-
gesting that cardiac work was unchanged. For citrulline, 
the fall in blood pressure was of sufficient magnitude to 
induce tachycardia to preserve RPP. In addition, apparent 
blood flow velocity, measured at the hand and foot, was 
also increased. This occurred despite a decrease in blood 
pressure, implying an increase in peripheral vascular con-
ductance (Levitt et al. 2015) and suggesting improved tis-
sue oxygenation. We, therefore, accept our hypothesis for 
cardiovascular improvements following nitrate and citrul-
line supplementation. Furthermore, assuming duplication 
of these effects in patients with HF we speculate that citrul-
line may potentially increase peripheral oxygen delivery.
We note a decrease in haemoglobin oxygen saturation 
(SaO2) following nitrate consumption which we propose 
is a consequence of methaemoglobin (mtHb) formation 
(Pluta et al. 2011). In contrast, studies exploiting beetroot 
juice, rich in nitrate, note no metHb (Kapil et al. 2015) and 
we postulate that this may relate to the use of KNO3 salt 
in cordial removing any potential matrix effects of food 
products and increasing rates of uptake. The onset and 
reversal of mtHb formation were previously noted to be 
rapid following the start and termination of nitrate infusion 
(Pluta et al. 2011), suggesting that rates of nitrate assimila-
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Fig. 4  Pulse Amplitude Ratio measured by infra-red plethysmogra-
phy. Effect of nitrate on pulse amplitude ratio (PAR) before and dur-
ing isometric grip exercise (a). Effect of citrulline on PAR before and 
during isometric grip exercise (b). For further details, see methods. 
Data represent mean ± SEM (n = 12 subjects). Statistical signifi-
cance indicated as: different from untreated control: *p < 0.05
Fig. 5  Estimate of sympatho-
vagal balance following nitrate 
and citrulline supplementation. 
Data represent heart rate varia-
bility measurements made from 
ECG recordings for subjects at 
rest and during breath-hold and 
isometric grip exercise. For fur-
ther details, see methods. Data 
represent mean ± SEM (n = 12 
subjects). Statistical significance 
indicated as: different from 
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formation of mtHb, this reduction of SaO2 was asympto-
matic (Pluta et al. 2011). Preservation of the pulse pressure 
despite decreases in diastolic pressure suggests that car-
diac contractile performance, and hence stroke volume, is 
maintained and the decrease in MAP is a consequence of 
decreased peripheral resistance. Previous experiments dem-
onstrated that both nitrate and citrulline supplementation 
induced acute vasodilatation in rodents (Chien et al. 2014), 
and increased nitric oxide production in vivo (Church-
ward-Venne et al. 2014; Schwedhelm et al. 2007). Dietary 
nitrate decreased DP in as little as 3 days (Larsen et al. 
2006) whilst citrulline use in humans decreased both SP 
and DP blood pressure following 14-days supplementation 
(Sanchez-Gonzalez et al. 2012; Figueroa et al. 2010). Fur-
thermore, supplementation of citrulline in human subjects 
increased plasma arginine (Moinard et al. 2008, 2015) and 
enhanced the bioavailability of nitric oxide (Morita et al. 
2014). Together these observations imply that both nitrate 
and citrulline have the potential to decrease BP through 
direct release of NO or the mobilisation of substrate for 
NOS. Perhaps critical for subjects with compromised car-
diac performance, neither nitrate nor citrulline altered RPP 
suggesting that cardiac work was preserved; therefore, 
despite a decrease in R–R interval and the modest tachy-
cardia noted for citrulline, the overall burden in cardiac 
mechanical performance was unchanged. Given that ‘rate 
work’ consumes more oxygen than increasing developed 
pressure (Hauton et al. 2015), indicates that citrulline may 
yield a modest increase in cardiac oxygen consumption.
Surprisingly, citrulline modestly decreased maximum 
voluntary contraction for ISGE. This was unexpected and 
may result from the potential for excess nitric oxide to dis-
rupt mitochondrial oxidative capacity (Bolanos et al. 1996; 
Clementi et al. 1998), but may also be a direct consequence 
of changes to blood pressure. Indeed, peak muscle blood 
flow is achieved at 30 % MVC-ISGE (Barnes 1980), and 
oxidative muscle performance is, in part, governed by 
blood pressure (Hobbs and McCloskey 1987).
Citrulline supplementation had only modest effects on 
cardiac electrical activity, including a small decrease in 
QRS interval duration for subjects at rest. Interestingly, 
when the apparent reduction in R–R interval is taken into 
account the QRS interval is preserved across all interven-
tions, suggesting that our observations were a direct result 
of the modest tachycardia caused by citrulline. These obser-
vations were in direct contrast to earlier studies showing a 
decrease in QTc interval (Kameda et al. 2011) following 
acute consumption of citrulline. Whilst exploiting the same 
citrulline dose as used in our current experiment, these 
observations were made after acute consumption of citrul-
line (60 min) (Kameda et al. 2011) whilst our experiment 
demonstrates the effects of chronic citrulline consumption.
Estimates of blood velocity in the peripheral circulation 
measured from the pulse interval indicate that both exog-
enous nitrate and citrulline increase the flow velocity meas-
ured at both hand and foot. The origins of this increase in 
velocity may be different for both nitrate and citrulline. 
Nitrate, converted to nitric oxide, may increase the dilata-
tion of vessels, decreasing the peripheral resistance. Evi-
dence in support of this was the decreased diastolic pres-
sure following nitrate consumption shown by ourselves and 
others (Levitt et al. 2015). The reduction in resistance with 
preserved cardiac performance, estimated as RPP, implies 
that flow and hence conductance have increased. Simi-
lar observations have been made following arginine sup-
plementation in HF patients implicating the production of 
exogenous NO in the reduction of systemic vascular resist-
ance (Bocchi et al. 2000). By contrast, the modest tachy-
cardia caused by consumption of citrulline may also con-
tribute to increasing flow velocity. Previous experiments in 
an elderly male population suggest that citrulline had no 
effect on blood flow in skeletal muscle (Churchward-Venne 
et al. 2014), although these authors postulate that the lack 
of effect for citrulline noted in their experiment may result 
from an inability to mobilise sufficient arginine to boost 
NO production. Moreover, impaired arginine transport has 
also been noted in HF (Kaye et al. 2000). Given that cit-
rulline also has the potential to cause vasodilatation, sec-
ondary to an increase in plasma arginine (Moinard et al. 
2008)—the substrate for nitric oxide synthase (NOS)—we 
cannot discriminate whether decreased vascular resistance 
or increased heart rate provides the greatest contribution 
to increases in flow velocity. Estimates of muscle oxygen 
































Fig. 6  Augmentation in heart rate when transitioning from rest 
to isometric exercise. Data represent the effect of nitrate or citrul-
line on the increase in HR noted during 30 % MVC isometric grip 
test. For further details, see methods. Data represent mean ± SEM 
(n = 12 subjects). Statistical significance indicated as: different from 
untreated control: *p < 0.05
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(NIRS) have highlighted that both nitrate (Bailey et al. 
2009) and citrulline (Bailey et al. 2015) may improve the 
efficiency of oxygen consumption during cycling exercise 
and, in consequence, may increase the time to exhaustion 
at fixed exercise loads. The origins of this improved effi-
ciency (decreased oxygen extraction at fixed workloads) 
are unclear but may reflect a decrease in fractional oxygen 
extraction as a consequence of increased conductance, or 
increases in the efficiency of oxidative phosphorylation 
(Bailey et al. 2009, 2015).
The position of the dicrotic notch in the peripheral blood 
flow signal, estimated as PAR, reflected the general vas-
cular tone in young adults (Klemsdal et al. 1996). Nitrate 
decreased the PAR at rest suggesting that a decrease in 
peripheral vascular tone (Bahra et al. 2012) was caused 
by nitrate or subsequent metabolites (Lund 1986). Previ-
ous experiments demonstrate that this effect is dependent 
upon nitric oxide or potential metabolites as arterial infu-
sion of nitric oxide synthase inhibitors blunted arterial 
elasticity that was restored by arginine infusion (McVeigh 
et al. 2001). Furthermore, infusion of GTN increased arte-
rial compliance (McVeigh et al. 2001).This would, in part, 
support the observations of potential increases in flow 
velocity as a consequence of decreased flow resistance. 
Interestingly, this effect was lost on the initiation of hand-
grip exercise raising the PAR to levels noted for untreated 
subjects. On relaxation, the PAR failed to return to pre-
exercise levels suggesting that generation of nitric oxide 
from nitrate was not restored to pre-test levels. The origins 
of this are unclear, but given that the half-time for NO is 
dependent upon pH, tissue oxygenation and the availability 
of nitrate (Kelm 1999) we cannot exclude the contribution 
from isometric exercise burden to NO breakdown. Indeed, 
superoxide radicals produced as a consequence of intense 
exercise may directly remove NO (Li and Forstermann 
2000; Silvestro et al. 2002).
By contrast, citrulline, whilst decreasing vascular tone 
before isometric exercise, went on to restore reduced vas-
cular tone directly after exercise. Previous experiments 
indicate that citrulline supplementation at similar doses 
to those used for our experiment decreased arterial stiff-
ness in middle-age men (Ochiai et al. 2012), implying 
that a greater effect may be provided by decreased resist-
ance (Sanchez-Gonzalez et al. 2012; Figueroa et al. 2010). 
This dichotomy may be a consequence of differences in 
the mechanism of action for both nitrate and citrulline. 
Namely, citrulline is an allosteric inhibitor of arginase 
enzyme, hence preventing the endothelial enzymic break-
down of arginine, the substrate for NOS, and raising the 
local arginine concentration (Berkowitz et al. 2006; Bailey 
et al. 2015) without increasing the plasma concentration 
of nitrate/nitrite (Hickner et al. 2006: Bailey et al. 2015). 
This may be less sensitive to prevailing effects of oxygen 
tension, superoxide production and pH than non-enzymic 
reduction of nitrate.
Examination of the heart rate variability (HRV) to quan-
tify the balance between sympathetic and parasympathetic 
tone, indicated by the LF/HF ratio, suggests that nitrate had 
no effect on the sympathovagal balance in young adults. By 
contrast, citrulline increased the level of sympathetic tone 
modestly at both rest and during exercise. Such changes 
may be responsible for the modest tachycardia we noted for 
subjects consuming citrulline. Similar observations were 
noted for previous experiments exploiting the same dose of 
citrulline measured after only 60 min, but no direct meas-
ure of HR was made during these experiments (Kameda 
et al. 2011). Interestingly, the impact on sympathetic tone 
was modest as a challenge to strongly stimulate the sym-
pathetic NS (a breath-hold) had no effect on the sympatho-
vagal balance when compared with untreated subjects. The 
modest stimulus presented by isometric exercise confirmed 
the effect of citrulline on sympathetic tone and was cor-
roborated by the lower augmentation in HR noted during 
exercise for citrulline-treated subjects.
Experimental shortcomings
No estimates of dietary nitrate intake were made for the 
subjects. We have assumed that all subjects maintained 
an equivalent nitrate intake throughout the experiment. 
Variability in our data for nitrate-treated subjects may be 
improved by estimating plasma nitrate or citrulline con-
centrations or restricting nitrate consumption. These may 
be useful additions in future experiments. Previous experi-
ments estimate that the pharmacokinetics of citrulline indi-
cate that the plasma half-life for citrulline may be 0.9 h 
(Moinard et al. 2008) compared with 5–8 h for dietary 
nitrate (Tannenbaum 1979) suggesting that the time delay 
between citrulline consumption and repeat experimenta-
tion may be critical. However, supplementation of older 
adults with citrulline elevated plasma arginine concen-
trations for up to 6 h (Moinard et al. 2015; Schwedhelm 
et al. 2007) suggesting little effect on plasma arginine 
levels during our sampling window. Our experiment takes 
no account of gender differences or stage of the men-
strual cycle for the female subjects. Interestingly, previous 
experiments suggest that different stages of the menstrual 
cycle had no effect on cardiac QT interval or autonomic 
tone (Burke et al. 1997) and indicate that gender differ-
ences in cardiac electrical activity are not a consequence 
of oestrogen (Burke et al. 1997). More recently, Minson 
et al. (2000) noted no effect of menstrual cycle stage on 
cardiovagal baroreflex sensitivity or vascular resistance. 
Together these imply that the changes we note are not 
likely to reflect difference in oestrogen status for female 
subjects.
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Conclusions
We demonstrate that both nitrate and citrulline decrease 
systemic blood pressure and increase vascular conductance, 
with the potential to increase peripheral tissue oxygena-
tion. These effects occur without altering cardiac electri-
cal activity suggesting that they may be safe adjuvants to 
cardiac therapies for patients with heart failure. Citrulline 
modestly alters sympathovagal balance to increase sympa-
thetic tone but this does not alter the vascular response to 
either citrulline or nitrate. Future experiments aim to inves-
tigate the effects of both nitrate and citrulline on peripheral 
tissue oxygenation and exercise capacity in HF and deter-
mine whether citrulline may perpetuate the increases in 
sympathetic tone noted in HF.
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